Education
About Us
Working with TipRanks
Follow Us
ISRA - ETF AI Analysis
Top Page
VanEck Israel ETF (ISRA)
Rating:71Outperform
Price Target:―
Positive Factors
Solid Recent Performance
The ETF has shown strong gains over the past three months and a positive trend year to date, indicating recent momentum.
Concentrated Exposure to Leading Israeli Companies
Many of the top holdings, especially major banks and defense-related firms, have delivered steady to strong performance, helping support the fund’s returns.
Diversified Across Key Sectors
Holdings spread across financials, technology, health care, and several smaller sectors help reduce the impact of weakness in any single industry.
Negative Factors
High Expense Ratio
The fund’s relatively high fee means more of the investment return goes to costs instead of staying in investors’ pockets.
Heavy Concentration in Financials and Technology
A large share of assets in just two sectors increases the risk that a downturn in financial or tech stocks could hurt overall performance.
Regional and Geopolitical Focus
The ETF’s strong tilt toward Israel, even with some U.S. exposure, makes it sensitive to regional economic and geopolitical developments.
ISRA vs. SPDR S&P 500 ETF (SPY)
AUM143.94M
RegionMiddle East & Africa
Expense Ratio0.59%
Beta0.79
IssuerVanEck
Inception DateJun 25, 2013
Dividend Yield1.37%
Asset ClassEquity
Index TrackedBlueStar Israel Global Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume10,835
30 Day Avg. Volume11,712
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
77.31Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering79
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ISRA Summary
The VanEck Israel ETF (ISRA) tracks the BlueStar Israel Global Index and gives you broad exposure to Israeli companies, including both local firms and Israel-linked businesses listed in the U.S. It holds a mix of financial, technology, and health care stocks, with well-known names like Teva Pharmaceutical and CyberArk Software. Someone might invest in ISRA to tap into Israel’s reputation as a “Start-Up Nation” and add international diversification to their portfolio. A key risk is that it is concentrated in one country, so its value can rise or fall sharply with economic or political events in Israel.
How much will it cost me?The VanEck Israel ETF (ISRA) has an expense ratio of 0.59%, which means you’ll pay $5.90 per year for every $1,000 invested. This is slightly higher than average because the fund is focused on a specific niche market (Israeli securities) and requires more active management compared to broad, passively managed index funds.
What would affect this ETF?The VanEck Israel ETF (ISRA) could benefit from Israel's strong reputation in technology and innovation, particularly in cybersecurity, biotechnology, and clean energy, which are key drivers of growth. However, potential risks include geopolitical tensions in the Middle East and global economic slowdowns, which could negatively impact the financial and industrial sectors that make up a significant portion of the ETF's holdings.
ISRA Top 10 Holdings
ISRA is leaning heavily on Israel’s big banks and a few standout innovators to do the heavy lifting. Financials like Leumi, Poalim, Discount, Mizrahi Tefahot, and Phoenix are steadily climbing and form the fund’s backbone, giving it a distinctly financial-sector tilt. On the growth side, Teva is recovering, while defense player Elbit Systems and chip-related names like Tower and Nova are rising and adding spark. Check Point, however, has been lagging lately, slightly dulling the shine of this all-Israel, tech-tinged portfolio.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Teva Pharmaceutical | 11.44% | $16.01M | $39.61B | 104.42% | 63 Neutral | |
| Leumi | 9.35% | $13.09M | ₪112.93B | 79.23% | 80 Outperform | |
| Poalim | 8.24% | $11.54M | ₪105.58B | 78.06% | 79 Outperform | |
| Elbit Systems | 6.09% | $8.53M | ₪107.92B | 144.82% | 73 Outperform | |
| Check Point | 3.76% | $5.26M | $17.61B | -26.64% | 76 Outperform | |
| Discount | 3.73% | $5.22M | ₪48.11B | 57.19% | 75 Outperform | |
| Mizrahi Tefahot | 3.40% | $4.75M | ₪63.77B | 129.24% | 80 Outperform | |
| Phoenix | 3.28% | $4.59M | ₪42.66B | 171.32% | 79 Outperform | |
| Tower | 2.67% | $3.74M | $14.34B | 184.60% | 76 Outperform | |
| Nova | 2.25% | $3.15M | $13.79B | 64.13% | 81 Outperform |
ISRA Technical Analysis
Positive
―
Price Trends
61.78
Positive
58.25
Positive
53.85
Positive
Market Momentum
0.55
Positive
54.16
Neutral
32.21
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ISRA, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 63.57, equal to the 50-day MA of 61.78, and equal to the 200-day MA of 53.85, indicating a neutral trend. The MACD of 0.55 indicates Positive momentum. The RSI at 54.16 is Neutral, neither overbought nor oversold. The STOCH value of 32.21 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ISRA.
ISRA Peer Comparison
Comparison Results
Performance Comparison
ISRA
VanEck Israel ETF
63.50
19.03
42.79%
SEIE
SEI Select International Equity ETF
―
―
―
FLGB
Franklin FTSE United Kingdom ETF
―
―
―
GSID
Goldman Sachs MarketBeta International Equity ETF
―
―
―
PID
Invesco International Dividend Achievers ETF
―
―
―
EIS
iShares MSCI Israel ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents